Our results demonstrate clearly that rmdTBI leads to cognitive dysfunction and brain degeneration, and that treatment with cis P-tau antibody prevents both the post-traumatic brain degeneration and the cognitive dysfunction. This evidence concerns the gene MAPT and neurodegenerative disease.